Vancouver, British Columbia–(Newsfile Corp. – November 10, 2022) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) (“Emerald” or the “Company”) announced today that its Plan...
Skye will continue to pursue Canadian Securities Exchange listing following closing of transaction Vancouver, British Columbia–(Newsfile Corp. – November 7, 2022) – Emerald Health Therapeutics, Inc....
Vancouver, British Columbia–(Newsfile Corp. – October 18, 2022) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) (“Emerald” or the “Company”) reports that it has provided...
Additional capital from Arrangement Agreement expected to fund Skye’s Phase 1 and 2 clinical studies of proprietary synthetic cannabinoid-derivative therapeutic targeting glaucoma San Diego, California–(Newsfile Corp....
Vancouver, British Columbia–(Newsfile Corp. – August 31, 2022) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) (“Emerald” or the “Company”) has reported financial results for...
Vancouver, British Columbia–(Newsfile Corp. – August 26, 2022) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) (“Emerald” or the “Company”) reports that on August 25, 2022,...
Vancouver, British Columbia–(Newsfile Corp. – August 19, 2022) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) (“Emerald” or the “Company”) reports that its shareholders voted...
Vancouver, British Columbia–(Newsfile Corp. – August 12, 2022) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) (“Emerald” or the “Company”) is providing an update and additional...
Vancouver, British Columbia–(Newsfile Corp. – August 12, 2022) – Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) (“Emerald” or the “Company”) announces that it has identified...
Vancouver, British Columbia–(Newsfile Corp. – July 12, 2022) – Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (CSE: EMH) (OTCQB: EMHTF) reports that it has received...